Clinical Trial Update: Study of DSP-7888 in Patients With Myelodysplastic Syndrome [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update for DSP-7888 in myelodysplastic syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndrome

Drugs mentioned

• DSP-7888

Snippet

Sponsor: Sumitomo Pharma Co., Ltd. | Conditions: Myelodysplastic Syndrome | Phase 1, Phase 2 | Status: COMPLETED